parallel randomized trial
S003090
Type 2 diabetes (adults)S003090
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | Standard care or no added treatment Basal plus (glargine) | insulin glargine once daily titrated to fasting glucose 100 to 140 mg/dL plus correction regular insulin before meals; oral agents stopped; lifestyle: not reported | 27 | ||
| A2 | Dulaglutide 0.75 mg subcutaneous once weekly Basal plus with dulaglutide | insulin glargine plus correction regular insulin before meals; oral agents stopped; lifestyle: not reported | 27 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Standard care or no added treatment A1 | Dulaglutide 0.75 mg subcutaneous once weekly A2 |
|---|---|---|---|
| age | mean (years) | 70.1 | 70.9 |
| age | sd (years) | 14 | 13 |
| bmi | mean (kg/m2) | 24.6 | 25.1 |
| bmi | sd (kg/m2) | 5.7 | 6.7 |
| diabetes duration | mean (years) | 10.1 | 8.7 |
| diabetes duration | sd (years) | 8.8 | 9.4 |
| hba1c | mean (percent) | 8.0 | 8.2 |
| hba1c | sd (percent) | 1.9 | 1.7 |
| other male | n | 18 | 15 |
| other male | percent | 67 | 56 |
Analyses this trial contributes to
- Level 2 or 3 hypoglycemia (participants)Type 2 diabetes (adults); longest follow-up; network meta-analysis
- Level 2 or 3 hypoglycemia (participants)Type 2 diabetes (adults); longest follow-up; network meta-analysis
- Level 2 or 3 hypoglycemia (participants)Type 2 diabetes (adults); longest follow-up; network meta-analysis
- Level 2 or 3 hypoglycemia (participants)Type 2 diabetes (adults); longest follow-up; network meta-analysis
Results
6 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Level 2 or 3 hypoglycemia (participants) (6 lines; O04)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 9 / 27 | not stated; modified itt; R0025350:Table 3 | ||||
| A1 | events | 1 / 27 | not stated; modified itt; R0025350:Table 3 | ||||
| A1 | events | 6 / 27 | not stated; modified itt; R0025350:Table 3 | ||||
| A2 | events | 3 / 27 | not stated; modified itt; R0025350:Table 3 | ||||
| A2 | events | 0 / 27 | not stated; modified itt; R0025350:Table 3 | ||||
| A2 | events | 1 / 27 | not stated; modified itt; R0025350:Table 3 |